3,259 search results for “this week s discoveries” in the Public website
-
Luuk van Middelaar launches his new book in London at LSE and UCL
This week, Prof. Luuk van Middelaar (Europa Institute) publishes Alarums & Excursions: improvising Politics on the Europen Stage – a revised update of his 2017 book on the decade of EU crises.
-
Get involved
The WIIS network is about the advancement of women's leadership. To best accomplish our mission, we need subscribers like you. As a dues-paying subscribers of Women In International Security (WIIS), you will have the ability to contribute to the WIIS Blog, receive WIIS this Week, access and post to…
-
Dutch Post-war Fiction Film through a Lens of Psychoanalysis
This week 'Dutch Post-war Fiction Film through a Lens of Psychoanalysis' by Peter Verstraten was published by Amsterdam University Press, the sequel to Humor and Irony in Dutch Post-war Fiction Film from 2016. Each chapter in his 482-page new study begins with a title of Fons Rademakers who made films…
-
The molecular secrets of medicinal cannabis
Chronic pain, nausea or vomiting due to chemotherapy. If you suffer from such ailments, medicinal cannabis can be a godsend. Though a downside is that it can make patients high. Therefore, Leiden researchers from the Oncode Institute are investigating alternatives that do not make you high. In Nature…
-
Inhibitor Selectivity: Profiling and Prediction
Less than 1 in 10 drug candidates that enter phase 1 clinical trials actually gets approved for human use.
-
Exploring the chemical space of post-translationally modified peptides in Streptomyces with machine learning
The ongoing increase in antimicrobial resistance combined with the low discovery of novel antibiotics is a serious threat to our health care.
-
Pascal chair 2023
Peter Flach is Professor of Artificial Intelligence at the University of Bristol. An internationally leading scholar in the evaluation and improvement of machine learning models using ROC analysis and calibration, he has also published on mining highly structured data, on knowledge-driven and explainable…
-
Finding and valorizing new antibiotics using AI
Antibiotics are a class of medicine most people take for granted. But pathogenic bacteria are becoming more and more resistant to our antibiotics, and this poses a great challenge for future treatments. There is thus a great societal need to identify new molecules that can address new targets and be…
-
Programme structure
The Drug Discovery and Safety specialisation consists of compulsory and optional components.
-
Discovery of selective diacylglycerol lipase β inhibitors
PhD defence
-
Discovery of Reversible Monoacylglycerol Lipase Inhibitors
PhD defence
-
Discovery and characterization of new glucosylated metabolites
PhD defence
-
Tom van der Wel
Science
t.van.der.wel@lic.leidenuniv.nl | +31 71 527 3534
-
Documentary From Aksum to India premiered during Week of Classics
For the annual Week of Classics, Dr Marike van Aerde and her team made a documentary about their research project Routes of Exchange, Roots of Connectivity. In the film the team touches upon the interactions of Greeks and Romans with the wider ancient world, ranging from the African kingdom of Aksum…
-
‘New students, tomorrow's world needs you!
'Today is the start of EL CID, the first of three introduction weeks at Leiden University. A new influx of students is ready and waiting, eager to get started. Vice-Rector Hester Bijl warmly welcomes all new first-years. ‘Go for it and grab your chances!’
- Leiden Science in 2023
-
Organisation
The Leiden Academic Centre for Drug Research (LACDR) is responsible for the research and education in Bio-Pharmaceutical Sciences carried out at Leiden University.
- Contact
-
Bachelor’s Open Days and Master’s Week will be completely online – and that has its advantages too
With interactive live presentations, a mass of chat opportunities and 360 degree videos, more prospective students than ever can gain a good impression of their chosen programme and the city they’re thinking of studying at. Instead of meeting up in the Pieterskerk or faculty buildings, thousands of…
-
History
Life Sciences Artificial Intelligence Data Science
-
Night of Discoveries with Leiden University researchers and fun activities
Festival
-
Oncode Accelerator
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process. Leiden University, the LUMC and other partners will implement this new way…
-
Determining the kinetic profile of ENT1 inhibitors
Supervisor: Anna Vlachodimou
-
Pursuing new anti-cancer therapy as a team
Cancer is the leading cause of death in the Netherlands, and, with over 100 different types of cancer, it’s not a simple disease. Today, skin, breast, lung, prostate and colon cancer are the most diagnosed forms. Therefore, the discovery and development of new drugs has the ability to significantly…
-
Leiden Academic Centre for Drug Research
The Leiden Academic Centre for Drug Research (LACDR) is a centre of excellence for multidisciplinary research on drug discovery and development.
-
‘Be open to other cultures’
This week more than 400 international students are starting their study programme in Leiden or The Hague. Why did they choose to study here? And what is the advice from their mentors?
-
Glycoproteomics assays for prostate cancer biomarker discovery
PhD defence
-
Teaching
At Molecular Physiology we teach the following courses within the Leiden Institute of Chemistry's Chemistry and Life Science and Technology programmes.
-
The Phantom of the Ego: Modernism and the Mimetic Unconscious
The Phantom of the Ego is the first comparative study that shows how the modernist account of the unconscious anticipates contemporary discoveries about the importance of mimesis in the formation of subjectivity.
-
The Complete Archaeology of Greece
This book covers the story of Greece and its central role in our understanding of European civilization, from the Palaeolithic era (400,000 BP) to the early modern period (1950 AD).
-
Translational pharmacokinetics-pharmacodynamics in zebrafish: integration of experimental and computational methods
The zebrafish is a promising vertebrate model organism in early drug discovery and development.
-
Zebrafish embryos and larvae as a complementary model for behavioural research
Promotor: Prof.dr. M.K. Richardson
-
Clavis Aurea? Structure-enabled approaches of identifying and optimizing GPCR ligands
Promotores: A.P. IJzerman, H.W.T. van Vlijmen
-
Quantitative pharmacological modelling for optimizing treatment of sepsis
Sepsis is a life-threatening condition caused by a dysregulated host response to infection, it is associated with significant morbidity, mortality, and with a high financial burden on global healthcare systems. Bacterial infections are the primary cause of sepsis, but the growing prevalence of antimicrobial…
-
Targeting the adenosinergic system
Adenosine is an endogenous ligand which exerts its action by activating adenosine receptors (ARs), while its circulating levels are controlled via a variety of mechanism and proteins, amongst others the equilibrative nucleoside transporters (ENTs).
-
Key publications
Key publications of the Computational Drug Discovery group
-
Contact
Do you have questions about the Bio-Pharmaceutical Sciences master’s programme or the specialisation Drug Discovery and Safety? Please contact us.
-
Novel immunomodulatory drugs for tuberculosis treatment
Can drugs that target host signaling pathways be used to eradicate antibiotic-resistant bacteria?
-
Leiden welcomes international students
If you're in Leiden this week, you can't miss the large groups of international students exploring the city. The Orientation Week Leiden (OWL) - the twice-yearly introduction week for international students - started on Tuesday 24 January, this time with more than 400 new students. ‘Every second building…
-
Unraveling temporal processes using probabilistic graphical models
Real-life processes are characterized by dynamics involving time. Examples are walking, sleeping, disease progress in medical treatment, and events in a workflow.
-
Career preparation
During the programme we will prepare you for your career as a legal professional in a global legal environment. Read more about the career preparation activities
-
The History of the Arabic Script: New Discoveries and Developments
Lecture, Workshop
-
Queen Máxima inspects zebrafish embryos
On Wednesday the 4th of September, Queen Máxima opened the renovated tropical greenhouse complex of the Leiden Hortus Botanicus. At the occasion Máxima met with IBL-PhD student Mahin Ghorbani from Iran and talked with her about her work on drug discovery from Iranian medicinal plants using zebrafish…
-
Chemical Probe Facility
The Chemical Probe Facility is part of the Leiden Early Drug Discovery & Development (LED3) center. Activity-based protein profiling (ABPP) is one of the pillars of chemical biology. ABPP determines the activity of entire protein families in living cells and tissues under physiological conditions, such…
-
Bio-organic Synthesis
The research in the Biosyn group is focused on the design, synthesis and function of the four major types of biomolecules: nucleic acids, carbohydrates, peptides and lipids and hybrid structures thereof. These biomolecules and their derivatives are used in drug discovery and chemical biology, to develop…
-
The Dakhleh Oasis Project
Update : March 2020 A.J. Mills
-
Biological and Soft Matter Physics
Research groups in the Biological & Soft Matter Programme unravel mechanisms in biological processes and develop novel bio-inspired soft materials.
-
Computational Network Science Lab
The Leiden Computational Network Science Lab (CNS Lab) researches methods for knowledge discovery from real-world network data.
-
Formation of synthetic fuel: new insights!
Navarro Paredes
-
Microvasculature in Microfluidics: matching complexity with compatibility
In vitro disease models play a fundamental role in drug research. They enable the systemic identification and validation of disease mechanisms and the discovery of possible drug targets. However, more than often, drug candidates that are identified in vitro fail in the later clinical stages of drug…